Skip to main content
. 2021 Jun 9;10(14):4905–4922. doi: 10.1002/cam4.4046

TABLE 1.

Incidence, disability‐adjusted life years (DALYs), and mortality of global skin cancers in 1990 and 2019 and the temporal trends from 1990 to 2019

Characteristics 1990 2019 EAPC (1990–2019)
Incidence DALYs Death Incidence DALYs Death ASIR ASDR ASMR
Numbers (95% UI)

ASR

No. ×10−5 (95% UI)

Numbers (95% UI)

ASR

No. ×10−5 (95% UI)

Numbers (95% UI)

ASR

No. ×10−5 (95% UI)

Numbers (95% UI)

ASR

No. ×10−5 (95% UI)

Numbers (95% UI)

ASR

No. ×10−5 (95% UI)

Numbers (95% UI)

ASR

No. ×10−5 (95% UI)

(95% CI) (95% CI) (95% CI)
Malignant skin melanoma
Global
Both 107380 (85128–134056) 2.56 (2.05–3.25) 1025669 (852906–1299132) 23.58 (19.62–29.92) 33083 (27827–43094) 0.85 (0.72–1.10) 289953 (214481–341965) 3.56 (2.63–4.19) 1707846 (1295585–1997465)

20.81

(15.78–24.33)

62844 (46317–71001) 0.79 (0.58–0.89) 1.13 (0.93–1.32)

−0.49

(−0.57, −0.41)

−0.27

(−0.36, −0.19)

Male 52168 (34828–70914) 2.71 (1.84–3.77) 559273 (404805–750910) 26.88 (19.37–36.32) 17624 (12796–24154) 0.99 (0.73–1.39) 153084 (89756–193326) 4.05 (2.34–5.06) 973502 (642004–1210394) 24.83 (16.21–30.76) 35425 (21971–42688) 0.98 (0.60–1.17) 1.38 (1.16–1.59)

−0.33

(−0.42, −0.24)

−0.04

(−0.14, 0.05)

Female 55212 (41148–72928) 2.48 (1.85–3.29)

466397

(392491–645042)

20.68

(17.43–28.75)

15459 (12944–21686) 0.73 (0.61–1.03) 136869 (92692–166593) 3.20 (2.18–3.90)

734345

(524702–882039)

17.28

(12.43–20.80)

27418 (18967–31888) 0.63 (0.44–0.74) 0.87 (0.69–1.05)

−0.68

(−0.75, −0.61)

−0.53

(−0.61, −0.46)

Socio‐demographic Index
High 76420 (57943–95320) 7.86 (5.93–9.66) 488331 (364154–610094) 50.60 (37.73–62.56) 16536 (12750–21901) 1.64 (1.26–2.16) 194489 (139700–237650) 12.40 (9.18–15.50) 743189 (521411–906594) 48.06 (34.82–59.93) 29419 (19479–34234) 1.63 (1.12–1.93) 1.79 (1.57–2.02)

−0.22

(−0.28, −0.16)

−0.04

(−0.09, 0.01)

High‐middle 22402 (18294–20247) 2.04 (1.68–2.72) 302047 (252900–391620) 26.97 (22.65–35.02) 9746 (8319–13057) 0.93 (0.80–1.25) 67629 (47547–78643) 3.54 (2.48–4.10) 490829 (356720–558876) 25.70 (18.81–29.57) 17965 (12942–20247) 0.91 (0.66–1.03)

2.02

(1.85 –2.19)

−0.33

(−0.49, −0.17)

−0.15

(−0.31, −0.01)

Middle 4988 (3866–6581) 0.44 (0.35–0.58) 126906 (96412–173680) 10.04 (7.69–13.55) 3770 (2905–5046) 0.37 (0.29–0.48) 17303 (13663–20507) 0.70 (0.55–0.83) 243560 (191742–291014)

9.51

(7.54–11.33)

8559 (6747–10203)

0.37

(0.29–0.44)

1.84

(1.73–1.96)

−0.19

(−0.23, −0.16)

0.00

(−0.04, 0.04)

Low‐middle 2103 (1497–3034) 0.32 (0.23–0.44) 61650 (42187–92963)

8.07

(5.67−11.82)

1768 (1254−2564) 0.30 (0.22−0.41) 6124 (4789−7242) 0.42 (0.33−0.50)

130964

(101688−157188)

8.52

(6.63−10.26)

4158 (3260−5001) 0.31 (0.24−0.37)

1.03

(0.99−1.07)

0.19 (0.17, 0.22) 0.19 (0.16, 0.23)
Low 1428 (924–2250) 0.50 (0.35–0.73) 46297 (28979–77576)

14.18

(9.40–21.77)

1248 (831–1931) 0.48 (0.34–0.69) 3222 (2445–4161) 0.51 (0.38–0.65) 98510 (74008–127212) 13.79 (10.24–17.49) 2713 (2014–3439) 0.47 (0.35–0.59)

0.22

(0.14, 0.30)

−0.13

(−0.15, −0.1)

−0.08

(−0.09, −0.06)

Malignant skin melanoma
Region
Asia Pacific, high income 1705 (1466–2237) 0.88 (0.75–1.16) 13346 (11901–18063)

6.78

(6.06–9.16)

458 (402–626) 0.24 (0.21–0.33) 5743 (3920–6910) 1.76 (1.20–2.11) 22747 (15186–26687)

7.07

(4.79–8.27)

1042 (722–1203) 0.24 (0.16–0.27) 2.65 (2.38, 3.93) 0.21 (0.09, 0.33)

0.05

(−0.04, 0.14)

Central Asia 552 (397–652) 1.12 (0.79–1.31) 10368 (7582–12138)

19.93

(14.53–23.16)

352 (249–408) 0.76 (0.53–0.88) 1014 (849–1444) 1.34 (1.13–1.90) 14473 (12176−20500)

15.47

(13.02–21.92)

489

(415–683)

0.73

(0.62–1.00)

−0.05

(−0.70, 0.03)

−1.16

(−1.58, −0.74)

−0.92

(−1.35, −0.48)

East Asia 3864 (2717–5427) 0.40 (0.29–0.56) 99670 (66737–143643) 9.52 (6.50–13.93) 2881 (1995–4217) 0.33 (0.24–0.48) 17349 (10980–21918) 0.91 (0.58–1.14) 157822 (102030–196625) 8.08 (5.27–10.05) 5456 (3576–6815)

0.28

(0.19–0.35)

3.28 (2.97,3.58) −0.52 (−0.64, −0.40)

−0.39

(−0.50, −0.29)

South Asia 1284(917–1800) 0.21 (0.15–0.28)

38905

(27418–56686)

5.26 (3.80–7.50) 1094 (791–1557) 0.20 (0.15–0.27) 3768 (2617–4571) 0.25 (0.18–0.30)

85960

(60777–103182)

5.38 (3.85–6.50) 2660 (1911–3222) 0.19 (0.14–0.24)

0.64

(0.59, 0.7)

0.05 (0, 0.1) −0.15 (−0.22, −0.07)
Southeast Asia 745 (582–1146) 0.26 (0.21–0.38) 22654 (17258–35353) 6.90 (5.40–10.48) 658 (521–993) 0.25 (0.20–0.36) 1716 (1359–2389) 0.28 (0.22–0.39)

42051

(33965–58361)

6.39

(5.14–8.83)

1434 (1148–1975) 0.25 (0.20–0.34)

0.23

(0.17, 0.28)

−0.32 (−0.34, −0.29)

−0.05

(−0.09, −0.02)

Australasia 7194 (5608–9420) 31.72 (24.55–41.32) 31241 (23438–41436)

138.36

(104.35–182.31)

1013 (787–1399) 4.41 (3.42–6.06) 18373 (12445–24061) 43.36 (30.23–57.02) 54107 (37983–69260) 128.92 (93.12–169.58) 2098 (1389–2511) 4.37 (2.96–5.41) 0.98 (0.79, 1.18) −0.25 (−0.35, −0.15) 0.01 (−0.1, 0.12)
Caribbean 209 (181–281) 0.75 (0.65–1.01)

3848

(3202–5503)

13.36 (11.18–18.79) 126 (106–175) 0.48 (0.41–0.66) 566 (447–749) 1.11 (0.87–1.46)

7250

(5736–9690)

14.26 (11.26–19.14) 268 (215–358) 0.52 (0.42–0.69)

1.22

(1.15, 1.28)

0.08

(−0.03, 0.18)

0.15 (0.06, 0.24)
Central Europe 5103 (4301–6768) 3.62 (3.06–4.78) 74977 (62565–98648) 53.32 (44.47–69.79) 2473 (2112–3334) 1.76 (1.50–2.37) 13818 (9945–16809) 7.73 (5.66–9.40)

105197

(74961–127277)

59.98

(43.25–73.01)

4144 (2878–4959) 2.09 (1.47–2.52) 2.76 (2.59, 2.94) 0.40 (0.29, 0.52) 0.66 (0.55, 0.77)
Malignant skin melanoma
Region
Eastern Europe 6747 (5609–9823) 2.54 (2.10–3.69)

99568

(79908–138634)

37.75 (30.06–52.09) 3173 (2651–4641) 1.19 (0.99–1.74) 17924 (13058–22508) 5.93 (4.36–7.44)

160338

(120985–193182)

54.83

(41.95–66.45)

5399 (4056–6515) 1.70 (1.28–2.06)

3.21

(2.99, 3.42)

0.99 (0.68, 1.31) 1.01 (0.72, 1.29)
Western Europe 34460 (27189–44244) 7.00 (5.47–8.92)

252769

(195891–336947)

51.79

(39.94–67.67)

8898 (7176–12092) 1.67 (1.33–2.26) 99643 (61381–119771) 14.55 (9.16–17.60) 393137 (237792–443322) 57.40 (35.15–65.13) 15922 (9412–17764) 1.89 (1.13–2.10)

2.58

(2.32, 2.84)

0.36 (0.26, 0.46) 0.48 (0.39, 0.56)
Andean Latin America 218 (166–316) 0.97 (0.75–1.37) 5638 (4218–8513) 22.71 (17.32–32.69) 186 (143–264) 0.89 (0.69–1.24) 786 (565–1104) 1.37 (0.99–1.92)

11979

(8569–17172)

20.56 (14.69–29.23) 475 (339–640) 0.86 (0.61–1.15)

1.41

(1.31, 1.51)

−0.20 (−0.28, 0.11)

0.07

(−0.02, 0.16)

Central Latin America 683 (601–994) 0.72 (0.62–1.03) 14901 (13197–22009) 14.34 (12.63–21.36) 472 (410–695) 0.55 (0.47–0.80) 3459 (2710–4716) 1.43 (1.12–1.95) 44445 (34503–61971)

18.16

(14.10–25.22)

1666 (1275–2249) 0.71 (0.54–0.96)

2.30

(2.18, 2.42)

0.75 (0.69, 0.80) 0.82 (0.76, 0.87)
Southern Latin America 732 (630–1077) 1.58 (1.36–2.32) 13090 (11270–19444) 27.90 (24.02–41.48) 448 (389–671) 0.99 (0.85–1.48) 2606 (1817–3486) 3.31 (2.32–4.44)

27609

(19727–34976)

35.44 (25.61–45.44) 1049 (742–1312) 1.28 (0.91–1.60)

2.33

(2.09, 2.57)

0.59 (0.41, 0.78) 0.71 (0.52, 0.91)
Tropical Latin America 1359 (1067–1816) 1.30 (1.01–1.73)

31294

(24617–43260)

27.87 (21.78–38.32) 929 (724–1271) 0.97 (0.75–1.32) 4921 (3944–6936) 2.02 (1.62–2.84) 70759 (58975–103756) 28.61 (23.88–41.90) 2514 (1971–3549)

1.05

(0.82–1.47)

1.47

(1.27, 1.66)

0 (−0.16, 0.17) 0.23 (0.09, 0.37)
North Africa and Middle East 1094 (639–1564) 0.57 (0.34–0.80)

26035

(14697–38550)

12.14

(6.93–17.66)

796 (463–1140) 0.47 (0.28–0.65) 3885 (2641–4669) 0.83 (0.55–1.00)

47804

(32044–58375)

9.58 (6.38–11.64) 1619 (1057–1957) 0.40 (0.26–0.48) 1.28 (1.20, 1.36)

−0.93

(−0.97, −0.88)

−0.62 (−0.66, −0.58)
North America, high income 39624 (28895–47582) 12.18 (8.81–14.43)

231788

(162648–277367)

72.36 (50.75–86.30) 7588 (5575–9540) 2.25 (1.65–2.81) 90002 (67857–118878) 16.62 (13.09–22.68)

342133

(264823–458947)

64.24 (51.69–89.70) 13202 (9438–16648) 2.20 (1.63–2.85)

1.86

(0.63, 1.09)

−0.55 (−0.61, −0.50)

−0.18

(−0.23, −0.14)

Malignant skin melanoma
Region
Oceania

16

(11–27)

0.48 (0.34–0.83)

478

(317–854)

12.49 (8.49–22.01)

14

(10–25)

0.49

(0.34–0.84)

36

(24–57)

0.48 (0.33–0.74)

1073

(694–1756)

12.13 (8.08–19.37) 33 (22–52)

0.48

(0.34–0.75)

−0.01

(−0.04, 0.02)

−0.04 (−0.07, −0.01) 0.02 (−0.01, 0.06)
Central Sub‐Saharan Africa 166 (108–281) 0.64 (0.44–0.93) 5288 (3297–9736) 17.11 (11.51–26.57) 148 (99–231) 0.63 (0.44–0.88) 412 (295–596) 0.67 (0.48–0.92)

11919

(8415–17619)

16.63

(11.84–23.56)

348 (249–493) 0.63 (0.44–0.86)

0.20

(0.13, 0.26)

−0.08

(−0.12, −0.04)

0.04 (0, 0.08)
Eastern Sub‐Saharan Africa 797 (521–1314) 0.83 (0.57–1.25) 26209 (16519–45722)

23.98

(16.12–37.68)

681 (456–1095) 0.77 (0.54–1.16) 1936 (1436–2685) 0.90 (0.66–1.20)

56660

(42429–78441)

23.36

(17.22–31.48)

1504 (1112–2017) 0.78 (0.57–1.03)

0.28

(0.22, 0.33)

−0.08

(−0.12, −0.04)

0.04

(0.01, 0.07)

Southern Sub‐Saharan Africa 400 (307–529) 1.31 (1.00–1.65)

10263

(7922–13964)

30.55 (23.39–39.96) 320 (243–411) 1.13 (0.84–1.42) 951 (638–1176) 1.59 (1.04–1.94)

21071

(14225–26144)

32.67

(21.66–39.86)

705 (458–856) 1.27 (0.80–1.53) 0.72 (0.64, 0.80)

0.34

(0.19, 0.50)

0.49

(0.33, 0.66)

Western Sub‐Saharan Africa 429 (275–608) 0.42 (0.28–0.56) 13340 (8025–20582)

11.26

(7.20–15.57)

375 (243–521) 0.40 (0.27–0.53) 1047 (707–1329) 0.45 (0.31–0.57) 29312 (20108–38381) 10.85 (7.38–13.83) 815 (559–1038) 0.40 (0.27–0.50)

0.34

(0.27, 0.41)

−0.08

(−0.13, −0.03)

0.08

(0.03, 0.12)

Non‐melanoma skin cancer (squamous‐cell carcinoma)
Global
Both 756481 (606882–933155) 22.27 (18.04–27.43)

561292

(518444–598784)

14.42 (13.30–15.40) 23222 (21441–24436) 0.69 (0.63–0.73) 2402221 (2122698–2712803) 30.30 (26.89–34.08)

1181530

(1084052–1262186)

14.64 (13.43–15.64) 56054 (50415–59792) 0.73 (0.65–0.78)

1.13

(0.50, 1.77)

0.20 (0.10, 0.30) 0.41 (0.34, 0.49)
Male 407454 (324920–512867) 28.15 (22.69–35.14)

346680

(312729–371315)

19.59 (17.63–21.01) 13696 (12374–14508) 0.95 (0.86–1.01) 1444114 (1263056–1652684) 41.39 (36.28–47.23)

741595

(681105–800732)

20.02

(18.42–21.62)

33244 (30347–35571) 1.01 (0.91–1.08)

1.38

(0.74, 2.03)

0.19

(0.09, 0.30)

0.40

(0.33, 0.48)

Female 349028 (282227–428879) 18.13 (14.67–22.28) 214612 (196484–238679)

10.28

(9.41 −11.38)

9526 (8681–10355) 0.50 (0.45–0.54) 958107 (844943–1080644) 21.84 (19.26–24.62) 439935 (386241–484874) 10.14 (8.91–11.17) 22809 (19350–25231)

0.52

(0.44–0.58)

0.71 (0.10, 1.33)

0.14

(0.03, 0.26)

0.36 (0.26, 0.45)
Non‐melanoma skin cancer (squamous‐cell carcinoma)
Socio‐demographic Index
High 706826 (562544–876862) 67.94 (54.74–84.13)

163231

(146023–184354)

16.03 (14.38–18.06) 6199 (5759–6394) 0.61 (0.56–0.63) 2252560 (1993685–2549163) 116.50 (102.73–132.17)

311830

(268493–365959)

16.64 (14.35–19.52) 13002 (11102–13900) 0.61 (0.53–0.64)

1.97

(1.3, 2.65)

0.2

(−0.1, 0.49)

0.20

(0.09, 0.31)

High‐middle 33081 (28641–38439) 3.52 (3.07–4.06) 162610(153561–170464) 15.84 (14.95–16.60) 7641 (7187–7973) 0.87 (0.80–0.91) 84828 (74907–95693) 4.24 (3.76–4.76) 278963 (255989–298819) 14.12 (12.96–15.12) 15469 (13914–16567) 0.80 (0.71–0.86)

0.67

(0.54, 0.8)

−0.36

(−0.44, −0.27)

−0.22 (−0.28, −0.16)
Middle 11348 (9800–13008) 1.34 (1.18–1.53) 151251 (138925–163475) 14.27 (13.13–15.40) 6009 (5529–6491) 0.73 (0.66–0.78) 44094 (37509–51378) 1.95 (1.67–2.24) 371726 (335341–406668) 15.38 (13.80–16.79) 17710 (15838–19361) 0.84 (0.75–0.92)

1.37

(1.29, 1.54)

0.55 (0.41, 0.69) 0.85 (0.69, 1.01)
Low‐middle 4047 (3518–4598) 0.85 (0.75–0.96) 66519 (54875–76684) 11.04 (8.97–12.59) 2657 (2142–3028) 0.57 (0.45–0.65) 14737 (12683–16987) 1.22 (1.06–1.40) 171270 (152501–187298) 12.73 (11.23–13.96) 7865 (6864–8605) 0.69 (0.59–0.76) 1.31 (1.25, 1.36) 0.68 (0.58, 0.78) 0.9 (0.77, 1.04)
Low 1112 (940–1298) 0.57 (0.50–0.66) 17352 (12141–20837) 7.42 (4.98–8.88) 701 (466–838) 0.39 (0.24–0.47) 8330 (5861–11397) 0.61 (0.53–0.70) 46978 (32488–55884) 8.91 (6.00–10.61) 2688 (2296–3113)

0.48

(0.31–0.57)

0.57

(0.47, 0.67)

0.7 (0.66, 0.73) 0.8 (0.75, 0.85)
Region
Asia Pacific, high income 1355 (1166–1578) 0.78 (0.67–0.91) 14507 (13906–15001) 7.55 (7.19–7.82) 729 (682–760) 0.43 (0.39–0.45) 6864 (5593–8285) 1.21 (0.99–1.44)

26707

(22953–28897)

6.00 (5.37–6.42) 2072 (1656–2306) 0.36 (0.30–0.40) 1.37 (1.19, 1.54)

−0.8

(−0.89, −0.7)

−0.57

(−0.65, −0.49)

Central Asia 896 (761–1040)

2.05

(1.75–2.36)

4567(4013–4956) 9.58 (8.35–10.43) 197 (168–216) 0.47 (0.39–0.52) 1851 (1582–2127) 2.91 (2.52–3.29) 11287 (9763–12527)

15.57

(13.31–17.14)

476 (404–522)

0.83

(0.70–0.91)

1.4 (1.17, 1.64) 2.32 (2.05, 2.6) 2.72 (2.43, 3.01)
East Asia 5723 (4880–6630) 0.80 (0.70–0.92) 133982 (117575–151252) 14.64 (12.90–16.45) 5180 (4578–5805) 0.70 (0.62–0.78) 41696 (35043–49043) 2.08 (1.76–2.42)

332831

(280835–384492)

16.60 (14.11–19.12) 15905 (13480–18220) 0.87 (0.74–0.99)

3.19

(3.01, 3.37)

1.03 (0.76, 1.3) 1.39 (1.09, 1.69)
Non‐melanoma skin cancer (squamous‐cell carcinoma)
Region
South Asia 1622 (1356–1912) 0.39 (0.33–0.45) 38950 (26205–47447) 7.13 (4.67–8.68) 1586 (1035–1935) 0.38 (0.24–0.47) 4507 (3817–5306) 0.38 (0.33–0.44)

90033

(69403–107258)

6.53 (5.02–7.76) 4130 (3139–4905) 0.35 (0.27–0.42)

−0.02

(−0.05, 0)

−0.44

(−0.5 −0.37)

−0.43

(−0.52, −0.35)

Southeast Asia 1871 (1657–2091) 0.86 (0.77–0.96) 43607 (37759–50243) 15.74 (13.65–18.02) 1642 (1418–1874)

0.74

(0.63–0.84)

4718 (4160–15333) 0.88 (0.79–0.98) 97002 (83967–109397) 15.66 (13.52–17.62) 4107 (3557–4596) 0.78 (0.67–0.87)

0.10

(0.04, 0.16)

−0.21

(−0.33, −0.1)

−0.05

(−0.17, 0.06)

Australasia 46825 (40005–54307) 202.89 (174.68–233.86)

8221

(8221–9247)

35.72

(32.33–40.23)

324 (301–346) 1.44 (1.32–1.54) 126454 (106605–148627) 249.75 (210.03–294.74) 19247 (16920–22056) 38.68 (34.11–44.15) 927 (804–1011) 1.70 (1.48–1.85)

0.58

(0.43, 0.73)

0.09

(0.01, 0.16)

0.39

(0.28, 0.51)

Caribbean 654 (582–723) 2.66 (2.38–2.94)

5425

(5085–5801)

20.89 (19.52–22.32) 269 (247–287) 1.15 (1.05–1.23) 1541 (1389–1705) 2.97 (2.68–3.29)

13295

(11186–15377)

25.72 (21.65–29.74) 739 (623–853) 1.41 (1.19–1.63)

0.41

(0.34, 0.47)

0.97 (0.85, 1.09) 0.97 (0.84, 1.09)
Central Europe 5194 (4710–5740) 3.87 (3.51–4.27)

31599

(28828–32548)

23.30

(21.10–24.07)

1774 (1602–1845) 1.47 (1.30–1.54) 9875 (8881–10925) 4.52 (4.07–4.99)

35219

(31119–39591)

17.01 (15.00–19.15) 2366 (2056–2657) 1.08 (0.94–1.21)

0.72

(0.65, 0.79)

−1.35

(−1.5, −1.2)

−1.33 (−1.52, −1.13)
Eastern Europe 6067 (5056–7195) 2.40 (2.01–2.80)

40503

(37517–42799)

15.30 (14.18–16.16) 1831 (1712–1961) 0.75 (0.70–0.81) 10101 (8403–12036) 2.93 (2.44–3.48)

55357

(49136–62205)

17.09 (15.12–19.10) 2894 (2573–3233) 0.86 (0.76–0.96)

0.97

(0.84, 1.11)

0.1

(−0.19, 0.4)

0.28 (0.03, 0.53)
Western Europe 32240 (28714–35726) 5.58 (4.99–6.20)

62068

(58376–63868)

11.29 (10.62–11.61) 3590 (3263–3728) 0.64 (0.57–0.66) 65275 (56889–74318) 6.87 (5.93–7.89)

89530

(79999–94768)

9.90 (9.04–10.44) 6563 (5572–7043) 0.60 (0.52–0.64)

0.89

(0.8, 0.99)

−0.24

(−0.38, −0.11)

0.07

(−0.08, 0.22)

Andean Latin America 420 (372–472) 2.23 (2.00–2.51)

3156

(2777–3680)

14.84 (13.10–17.17) 145 (128–165) 0.81 (0.71–0.91) 1436 (1256–1629) 2.65 (2.31–3.00)

10191

(8165–12331)

18.10 (14.53–21.84) 569 (467–677) 1.06 (0.87–1.27) 0.69 (0.61, 0.77)

0.77

(0.63, 0.91)

1.12 (0.96, 1.27)
Non‐melanoma skin cancer (squamous‐cell carcinoma)
Region
Central Latin America 3658 (3149–4197) 4.79 (4.14–5.47) 21064 (19848–21785) 24.18 (22.60–25.08) 922 (853–961) 1.28 (1.16–1.34) 11594 (10005–13283) 5.07 (4.39–5.81)

50565

(43604–58328)

21.46 (18.44–24.75) 2757 (2343–3152) 1.23 (1.04–1.40)

0.34

(0.25, 0.43)

−0.53

(−0.58, −0.49)

−0.23

(−0.28, −0.18)

Southern Latin America 2593 (2247–2955) 5.98 (5.20–6.80) 6628 (6167–7213) 14.80 (13.74–16.16) 326 (301–359) 0.80 (0.73–0.88) 8335 (7276–9461) 9.86 (8.61–11.16) 13297 (12036–14079) 16.10 (14.57–17.05) 803 (704–861)

0.94

(0.83–1.01)

1.62 (1.32, 1.93)

0.31

(0.27, 0.35)

0.66 (0.61, 0.71)
Tropical Latin America 2560 (2192–2967) 2.99 (2.57–3.45) 19449 (18621–20268) 20.68 (19.56–21.60) 801 (753–839) 1.06 (0.97–1.12) 12085 (10224–14065) 5.07 (4.29–5.91)

53225

(48153–56188)

22.10 (19.88–23.36) 2805 (2424–3000) 1.22 (1.05–1.31)

1.89

(1.75, 2.03)

0.35

(0.28, 0.42)

0.72 (0.65, 0.79)
North Africa and Middle East 1503 (1300–1718) 1.03 (0.91–1.16) 15483 (13523–17893)

9.11

(7.81–10.58)

667 (563–778) 0.50 (0.41–0.60) 4347 (3782–4943) 1.15 (1.01–1.30) 38526 (34637–43203) 9.08 (8.11–10.14) 1845 (1636–2063) 0.54 (0.47–0.61) 0.45 (0.26, 0.64)

0.01

(−0.04, 0.06)

0.33 (0.20, 0.47)
North America, high income 641232 (500514–807198) 179.63 (141.66–224.05) 94769 (79206–115168) 27.60 (23.24–33.08) 2528 (2335–2609) 0.72 (0.66–0.74) 2085597 (1843524–2366411) 324.18 (285.94–368.52) 193954 (155776–243557) 30.91 (25.05–38.75) 5000 (4332–5316) 0.75 (0.66–0.79) 2.2 (1.46, 2.95) 0.42 (−0.02, 0.87) 0.29 (0.16, 0.43)
Oceania 14 (13–16) 0.67 (0.61–0.74) 390 (481–317) 13.11 (10.78–16.05)

15

(12–18)

0.70 (0.57–0.85) 38 (34–42) 0.71 (0.65–0.78) 1044 (802–1387) 14.56 (11.53–18.65)

40

(32–52)

0.80 (0.65–0.98) 0.24 (0.21, 0.27) 0.41 (0.35, 0.48) 0.50 (0.44, 0.56)

Central

Sub‐Saharan Africa

139 (116–165) 0.77 (0.67–0.88) 1875 (1281–2371) 8.55 (5.48–10.93) 73 (47–93) 0.46 (0.27–0.60) 379 (321–444) 0.85 (0.75–0.98) 5711 (3938–7499)

10.62

(6.98–13.89)

227 (149–298) 0.57 (0.36–0.75)

0.47

(0.37, 0.57)

0.86

(0.77, 0.94)

0.83 (0.75, 0.91)

Eastern

Sub‐Saharan Africa

477 (402–557) 0.78 (0.68–0.89)

6417

(3959–7954)

8.78 (5.12–11.06) 266 (153–335) 0.48 (0.25–0.62) 1205 (1030–1408) 0.87 (0.76–1.00) 18836 (11106–23606) 11.66 (6.54–14.69) 814 (450–1029) 0.66 (0.34–0.84)

0.47

(0.40, 0.55)

1.12

(1.06, 1.18)

1.23 (1.17, 1.29)
Non‐melanoma skin cancer (squamous‐cell carcinoma)
Region

Southern

Sub‐Saharan Africa

1103 (895–1337) 4.21 (3.44–5.05)

3365

(2843–3755)

12.13 (10.12–13.60) 151 (125–170) 0.65 (0.54–0.74) 3514 (2854–4246) 6.51 (5.29–7.82)

8692

(7839–9435)

15.72 (14.19–17.00) 401 (362–433) 0.86 (0.77–0.93)

1.25

(0.62, 1.89)

1.21

(1.09, 1.32)

1.23 (1.13, 1.33)
Western Sub‐Saharan Africa

335

(284–392)

0.42 (0.37–0.49) 5268 (4410–6211) 5.64 (4.68–6.64) 205 (169–240) 0.27 (0.22–0.32)

810

(688–942)

0.48 (0.42–0.56) 16980 (12876–20755) 7.71 (5.90–9.26) 612 (471–732) 0.38 (0.29–0.44)

0.56

(0.52, 0.59)

1.30 (1.18, 1.41)

1.33

(1.22, 1.45)

Non‐melanoma skin cancer (basal‐cell carcinoma)
Global
Both 1194817 (1003244–1414118) 31.82 (26.70–37.62) 562 (257–1040)

0.01

(0.01–0.03)

3951466 (3488307–4463602) 48.80 (43.11–55.01) 1703 (782–3191) 0.02 (0.01–0.04)

2.23

(1.75, 2.72)

1.89

(1.46, 2.33)

Male 603786 (503497–720199) 37.34 (31.35–44.48) 274 (126–516)

0.02

(0.01–0.03)

2238819 (1971821–2534569) 61.42 (54.30–69.59) 933 (431–1739) 0.03 (0.01–0.05)

2.6

(2.04, 3.16)

2.25 (1.75, 2.75)
Female 591031 (495555–693623) 28.37 (23.81–33.24) 288 (131–537)

0.01

(0.01–0.03)

1712647 (1509698–1929286) 39.31 (34.70–44.26) 770 (357–1443)

0.02

(0.01–0.03)

1.75

(1.32, 2.18)

1.44 (1.06, 1.82)
Socio‐demographic Index
High 869169 (725323–1042112) 84.49 (70.68–100.13) 385 (178–707)

0.04

(0.02–0.07)

3092344 (2747219–3465310) 172.17 (153.37–191.24) 1250 (583–2320) 0.07 (0.03–0.13)

3.48

(2.88, 2.09)

3.14 (2.58, 3.7)
High‐middle 203645 (175779–234580) 19.56 (16.97–22.49) 110 (51–208)

0.01

(0.00–0.02)

444878 (374730–520353) 22.06 (18.64–25.71) 233 (107–450)

0.01

(0.01–0.02)

0.43 (0.33, 0.54)

0.37

(0.28, 0.46)

Non‐melanoma skin cancer (basal‐cell carcinoma)
Socio‐demographic Index
Middle 81030 (67540–95851) 7.97 (6.64–9.36) 46 (21–88)

0.00

(0.00–0.01)

282680 (233627–331957) 11.38 (9.48–13.33)

159

(71–302)

0.01

(0.00–0.01)

1.44 (1.23, 1.64) 1.24 (1.05, 1.43)
Low‐middle 32233 (26643–38697) 5.60 (4.64–6.63) 17 (8–32)

0.00

(0.00–0.01)

97519 (78989–117419) 7.11 (5.79–8.47) 50 (22–95)

0.00

(0.00–0.01)

0.81

(0.70, 0.93)

0.75 (0.64, 0.86)
Low 8469 (6574–10699) 3.37 (2.66–4.15) 4 (2–9)

0.00

(0.00–0.00)

19022 (14945–24120) 3.37 (2.67–4.15)

10

(5–20)

0.00

(0.00–0.00)

0.21

(0.08, 0.33)

0.13 (0.02, 0.24)
Region
Asia Pacific, high income 5305 (4314–6415) 2.74 (2.25–3.29) 4 (2–8)

0.00

(0.00–0.00)

17425 (14628–20804) 3.95 (3.30–4.73)

14

(6–27)

0.00

(0.00–0.01)

0.91

(0.80, 1.02)

0.76 (0.65, 0.86)
Central Asia 10413 (8272–12612) 22.65 (18.07–27.23)

6

(2–11)

0.01

(0.01–0.02)

16635 (12955–20530) 22.82 (18.02–27.70) 9 (4–17)

0.01

(0.01–0.02)

0.03

(0.02, 0.04)

0.0

(−0.01, 0.01)

East Asia 34453 (28170–41956) 3.78 (3.10–4.53) 23 (10–44)

0.00

(0.00–0.00)

246958 (206646–285908) 11.78 (9.97–13.55) 142 (63–275)

0.01

(0.00–0.01)

3.94

(3.4, 4.48)

3.52 (3.05, 3.99)
South Asia 8417 (6254–11419) 1.29 (0.97–1.66) 5 (2–9)

0.00

(0.00–0.00)

21286 (16355–27557) 1.42 (1.10–1.79) 12 (2–23)

0.00

(0.00–0.00)

0.36

(0.30, 0.41)

0.38

(0.33, 0.43)

Southeast Asia 5830 (4928–6795) 2.27 (1.94–2.63)

4

(2–7)

0.00

(0.00–0.00)

9981 (7485–12794) 1.63 (1.25–2.05) 6 (3–13)

0.00

(0.00–0.00)

−0.69

(−0.98, −0.40)

−0.65

(−0.91, −0.39)

Non‐melanoma skin cancer (basal‐cell carcinoma)
Region
Australasia 6725 (5294–8159) 29.25 (23.23–35.33) 4 (2–8)

0.02

(0.01–0.03)

13722 (10977–16820) 29.45 (23.54–35.74) 8 (4–16)

0.02

(0.01–0.03)

0.15

(0.04, 0.25)

0.10

(0.03, 0.18)

Caribbean 1960 (1573–2377) 7.44 (5.96–8.99) 1 (1–2)

0.00

(0.00–0.01)

3250 (2535–3980) 6.28 (4.91–7.70)

2

(1–4)

0.00

(0.00–0.01)

−0.58

(−0.69, −0.47)

−0.57

(−0.66, −0.47)

Central Europe 33348 (29301–37879) 23.09 (20.47–26.05) 18 (8–35)

0.01

(0.01–0.02)

62142 (51628–73676) 29.45 (24.72–34.49)

32

(15–61)

0.02

(0.01–0.03)

1.01 (0.87, 1.15) 0.83 (0.72, 0.94)
Eastern Europe 44224 (35328–53344) 16.17 (12.99–19.30) 24 (11–47)

0.01

(0.00–0.02)

65244 (51565–79858) 19.21 (15.24–23.24) 35 (16–68)

0.01

(0.00–0.02)

0.54

(0.48, 0.60)

0.45 (0.39, 0.51)
Western Europe 205656 (182848–232562) 36.60 (32.62–40.90) 115 (54–213)

0.02

(0.01–0.04)

315155 (255014–382285) 36.62 (29.67–44.13)

173

(80–327)

0.02

(0.01–0.04)

0.35

(0.17, 0.53)

0.29

(0.15, 0.44)

Andean Latin America 3493 (3142–3867) 17.39 (15.66–19.30)

2

(1–4)

0.01

(0.00–0.02)

8723 (6957–10631) 15.63 (12.53–19.11)

5

(2–10)

0.01

(0.00–0.02)

−0.21

(−0.52, 0.11)

−0.14 (−0.39, 0.11)
Central Latin America 24699 (20128–29561) 29.25 (23.89–35.01) 14 (6–26)

0.02

(0.01–0.03)

68781 (55333–82361) 29.16 (23.54–35.01) 37 (17–72)

0.02

(0.01–0.03)

0.01

(0.00, 0.01)

−0.11

(−0.02, 0.00)

Southern Latin America 10458 (9027–11991) 22.97 (19.85–26.33)

6

(3–12)

0.01

(0.01–0.03)

18645 (14878–22684) 22.61 (18.02–27.38)

11

(5–21)

0.01

(0.01–0.02)

−0.19

(−0.30, −0.08)

−0.18

(−0.27, −0.08)

Non‐melanoma skin cancer (basal‐cell carcinoma)
Region
Tropical Latin America 62198 (54790–70592) 67.11 (59.09–76.34) 26 (12–50)

0.03

(0.01–0.05)

178574 (155353–204151) 73.40 (63.75–83.86)

75

(35–143)

0.03

(0.01–0.06)

0.47

(0.33, 0.60)

0.52 (0.39, 0.65)
North Africa and Middle East 12758 (10657–15003) 7.43 (6.23–8.67)

8

(4–15)

0.00

(0.00–0.00)

29927 (23994–36217) 6.83 (5.50–8.26)

19

(8–36)

0.00

(0.00–0.01)

−0.02

(−0.31, 0.26)

−0.04 (−0.28, 0.21)
North America, high income 713279 (585827–865410) 253.90 (208.54–308.06)

296

(137–541)

0.00

(0.00–0.01)

2848027 (2537042–3178992) 781.22 (695.92–872.01)

1109

(518–2068)

0.00

(0.00–0.01)

4.07

(3.32, 4.82)

3.86

(3.12, 4.60)

Oceania

6

(3–10)

0.12 (0.06–0.20)

0

(0–0)

0.00

(0.00–0.00)

14 (6–23) 0.12 (0.06–0.19)

0

(0–0)

0.00

(0.00–0.00)

−0.01

(−0.01, 0.00)

−0.11

(−0.12, −0.11)

Central Sub‐Saharan Africa 1093 (826–1400) 4.57 (3.53–5.68)

1

(0–1)

0.00

(0.00–0.00)

2635 (1981–3411) 4.50 (3.44–5.59)

1

(1–3)

0.00

(0.00–0.00)

−0.05 (−0.07, −0.03)

−0.08

(−0.10, −0.06)

Eastern Sub‐Saharan Africa 3122 (2414–3962) 3.85 (3.02–4.76)

2

(1–3)

0.00

(0.00–0.00)

6876 (5303–8777) 3.76 (2.94–4.64)

4

(2–7)

0.00

(0.00–0.00)

−0.10

(−0.13, −0.08)

−0.12 (−0.14, −0.09)
Southern Sub‐Saharan Africa 4820 (3847–5885) 16.72 (13.24–20.42)

2

(1–5)

0.01

(0.00–0.02)

11702 (9253–14384) 19.85 (15.60–24.23) 6 (3–11)

0.01

(0.00–0.02)

0.17

(−0.43, 0.77)

0.15 (−0.37, 0.68)
Western Sub‐Saharan Africa 2560 (1937–3333) 2.66 (2.03–3.33)

1

(1–3)

0.00

(0.00–0.00)

5766 (4330–7588) 2.67 (2.04–3.35)

3

(1–6)

0.00

(0.00–0.00)

0.01

(−0.02, 0.04)

−0.02

(−0.05, 0.02)

Data from a total of 204 countries and territories were available. Geographically, the world was classified as 21 regions, on the basis of geographical proximity, sociocultural, and epidemiological similarities. The Socio‐demographic Index (SDI) is a summary measure of development status strongly correlated with health outcomes. According to the SDI 204 countries and territories were separated into 5 regions with low, low‐middle, middle, high‐middle, and high SDI.

Abbreviations: ASDR, age‐standardized disability‐adjusted life years (DALYs) rate; ASIR, age‐standardized incidence rate; ASMR, age‐standardized mortality rate; ASR, age standardized rate (per 100,000 population); CI, confidence interval; EAPC, estimated annual percentage change; SDI, socio‐demographic index; UI, uncertainty interval.